The IPO Window Reopens for Small Caps

Key Takeaways

• 2025 saw 371 U.S. IPOs, up 40% from 2024
• Russell 2000 trades at ~18× forward earnings, 31% discount to S&P 500
• Bloomberg projects 43% earnings growth for Russell 2000 over next year
• Policy changes like bonus depreciation boost cash flow for capital‑intensive small caps
• PE firms' exit backlog fuels continued small‑cap IPO pipeline through 2026

Pulse Analysis

The resurgence of U.S. IPO activity is reshaping capital markets after a post‑2021 drought. MicroVentures reports 371 listings in 2025, driven by private‑equity firms eager to unlock pent‑up exit demand. As limited partners pressure general partners for distributions, the backlog of high‑growth private companies is translating into a steady stream of small‑cap offerings. This trend not only diversifies the public market’s supply side but also re‑introduces fresh capital to sectors that have been under‑represented since the mega‑cap tech boom.

Small‑cap equities are now trading at a compelling discount relative to their large‑cap peers. The Russell 2000’s forward price‑to‑earnings multiple sits near 18×, roughly 31% lower than the S&P 500’s 26×, the widest spread in over a quarter‑century. Coupled with Bloomberg’s consensus forecast of 43% earnings growth for the Russell 2000 versus 11% for the S&P 500, the valuation gap creates a potent earnings‑multiple arbitrage opportunity. Institutional investors are rotating into domestic‑focused, high‑growth firms, driving three‑year highs in small‑cap trading volumes and reinforcing the sector’s momentum.

Legislative support and robust dealmaking amplify the upside. The One Big Beautiful Bill Act, enacted in mid‑2025, restores immediate R&D expensing and expands bonus depreciation, directly enhancing cash flow for capital‑intensive small firms. Meanwhile, EY‑Parthenon projects a 3% rise in overall M&A volume for 2026, with Deloitte’s survey indicating expectations of larger, more frequent deals. These dynamics can trigger re‑ratings and acquisition premiums across small‑cap sectors. Though floating‑rate debt exposure and a looming maturity wall pose risks, the convergence of a healthy IPO pipeline, valuation discounts, earnings acceleration, and policy tailwinds makes small‑cap investing increasingly hard for allocators to ignore.